The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
about
Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study.Lipoprotein (a) and atherogenic indices in Sudanese patients with type 2 diabetes.Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathyChronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?Prevalence of chronic complication among type 2 diabetics attending primary health care centers of Al Ahsa district of Saudi Arabia: a cross sectional survey.Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetesDifferent Risk Indictors of Diabetic Nephropathy in Transforming Growth Factor-beta1 T869C CC/CT Genotype and TT Genotype.Anterior Diabetic Retinopathy Studied by Ultra-widefield Angiography.Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study.Lipoprotein-associated phospholipase A₂ mass level is increased in elderly subjects with type 2 diabetes mellitus.Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN)Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: A 10-year prospective study.Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.[HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DM.Japanese Clinical Practice Guideline for Diabetes 2016.Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes Mellitus and Diabetic Nephropathy.Diabetische RetinopathieTangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice.Thyroid stimulating hormone and free triiodothyronine are valuable predictors for diabetic nephropathy in patient with type 2 diabetes mellitus
P2860
Q34347027-EC217CEC-102B-45A0-9434-4D09C214F184Q34638701-4CE17F7F-1219-4A1B-9232-5CCAE7FA242AQ35595619-25FF0E0F-E8CE-437F-8FF5-CE1FB62DDBE9Q36402823-4458D30C-2995-400A-A66B-B2CE1EE4D839Q36411656-F2DA17DF-C8DB-41BC-BC60-36D8399C7ECAQ36780025-150B2641-2747-473B-A436-0D0B7DF2C80BQ37112920-927566B4-4F38-4457-8085-F2DF154DECC0Q37262935-30C2A8B6-BA16-4C90-80B1-ABA8B35D6D17Q37325132-7096E4E1-1023-4173-923C-CD035F9D1B8FQ37392958-25B892C8-CE55-4783-A0D4-BD4459FC1314Q37600743-0AA41160-A73A-4FEB-9B10-4775505328B1Q37730748-010367A6-0DAC-40DB-B5AE-4DB74713B899Q38698725-809BF139-9E70-4A53-A24B-31A8143EB90AQ41665516-FF51EB5A-7828-43F1-9A0D-D300F94A1A7DQ42658261-69F5699C-0B1F-44AD-8AA8-7D15EC9B7C5DQ45072634-8C04684F-0992-4A71-8CD1-F5EF10FA0108Q46942263-94AE4A58-E281-4A43-91F4-D53FFBC982D1Q48331580-411D17BF-7BE0-4AB7-B419-FC81BAB4FACCQ55069710-FE206697-FEA2-482A-88D0-90382FE562A5Q55091608-10EB8C99-568E-493D-A769-EAB58ED8CDC9Q55109775-AF9D077F-DB89-4EF7-B123-BEB945BE4650Q55234574-4087CBEF-73AC-468B-A3EE-5DE8C9C4AC63Q58804787-1FF19B04-7F71-400A-855B-B0A6F351E384
P2860
The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The impact of serum lipids on ...... with type 2 diabetes mellitus.
@ast
The impact of serum lipids on ...... with type 2 diabetes mellitus.
@en
type
label
The impact of serum lipids on ...... with type 2 diabetes mellitus.
@ast
The impact of serum lipids on ...... with type 2 diabetes mellitus.
@en
prefLabel
The impact of serum lipids on ...... with type 2 diabetes mellitus.
@ast
The impact of serum lipids on ...... with type 2 diabetes mellitus.
@en
P2093
P2860
P356
P1476
The impact of serum lipids on ...... with type 2 diabetes mellitus.
@en
P2093
Dawn Koselleck
Mark J Cziraky
Peter P Toth
Ralph A Quimbo
Robert J Simko
Swetha Rao Palli
P2860
P2888
P356
10.1186/1475-2840-11-109
P407
P577
2012-09-14T00:00:00Z
P5875
P6179
1031688539